Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros











Base de datos
Intervalo de año de publicación
1.
Epidemiology ; 31(5): 692-694, 2020 09.
Artículo en Inglés | MEDLINE | ID: mdl-32740471

RESUMEN

In trials with noncompliance to assigned treatment, researchers might be interested in estimating a per-protocol effect-a comparison of two counterfactual outcomes defined by treatment assignment and (often time-varying) compliance with a well-defined treatment protocol. Here, we provide a general counterfactual definition of a per-protocol effect and discuss examples of per-protocol effects that are of either substantive or methodologic interest. In doing so, we seek to make more concrete what per-protocol effects are and highlight that one can estimate per-protocol effects that are more than just a comparison of always taking treatment in two distinct treatment arms. We then discuss one set of identifiability conditions that allow for identification of a causal per-protocol effect, highlighting some potential violations of those conditions that might arise when estimating per-protocol effects.


Asunto(s)
Protocolos Clínicos , Ensayos Clínicos Controlados Aleatorios como Asunto , Causalidad , Humanos , Cooperación del Paciente , Resultado del Tratamiento
2.
J Pediatr ; 167(5): 1096-102.e3, 2015 Nov.
Artículo en Inglés | MEDLINE | ID: mdl-26372535

RESUMEN

OBJECTIVES: To estimate the effects of antibiotic exposures in the first 6 months of life on short- and long-term growth. STUDY DESIGN: In a prospective observational cohort study of 497 children from Vellore, India, we estimated short-term effects of antibiotics during the first 6 months using longitudinal general linear regression to model weight-for-age, height-for-age, and weight-for-height z-scores in monthly intervals. To estimate long-term effects, we modeled growth from 6 months to 3 years as a function of antibiotic use in the first 6 months. We also estimated the effects of antibiotics on the monthly relative risks of underweight, stunting, and wasting in the first 6 months and to 3 years. RESULTS: Underweight, stunting, and wasting were common in this population: 31%, 32%, and 15% on average after 6 months of age, respectively. There was no association between antibiotic exposures before 6 months and growth during that period. From 6 months to 3 years, adjusted absolute differences in weight and height were small (approximately -100 g and no more than -2 mm overall, respectively) and not statistically significant. CONCLUSIONS: Antibiotic exposures early in life were not associated with increased or decreased growth. The combination of malnutrition and recurrent illness likely complicate the relationship between antibiotic exposures and growth among children in low and middle-income countries.


Asunto(s)
Antibacterianos/uso terapéutico , Estatura/fisiología , Peso Corporal/fisiología , Criptosporidiosis/tratamiento farmacológico , Trastornos del Crecimiento/epidemiología , Preescolar , Criptosporidiosis/fisiopatología , Femenino , Estudios de Seguimiento , Trastornos del Crecimiento/etiología , Humanos , Incidencia , India/epidemiología , Lactante , Recién Nacido , Masculino , Estudios Prospectivos , Factores de Riesgo , Factores de Tiempo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA